SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A BC DE FG H IJ KL MN OP QR ST UV WX YZ

Browse current Australian managed funds

0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

EVE INVESTMENTS LIMITED (EVE)

Listed on ASX

SHARE PRICES

(updated weekly)

Former (or subsequent) names

Shareholder links

Our website ranking of EVE: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services, Level 12 QV1 Building 250 St Georges Terrace Perth WA 6000

Tel : +61 8 9211 6670 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: Suite 1, 245 Churchill Avenue Subiaco WA 6008
Tel:  +61 8 6465 5500 Fax: +61 8 6465 5599

Date first listed: 08/04/2004
Company Secretary: Steven Jackson
Sector: Energy Industry Group: XEJ
Activities: Investment in mineral exploration companies

The suspension of trading in the securities of Eve Investments Limited will be lifted from the commencement of trading on Friday, 6 December 2019, following the release by EVE of an announcement regarding a capital raising.

06/12/2019

First subscription funds of $2.4m have been received by the company. Shares to be allotted early next week. Funds used to expand Meluka Health and Jenbrook business activities.

06/12/2019

At the company's 12 November 2019 AGM, shareholders passed a special resolution to amend the company's constitution. A copy of the constitution is then released to the market.

04/12/2019

The securities of EVE Investments Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EVE, pending the release of an announcement regarding a capital raising.

29/11/2019

The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by EVE of an announcement regarding a capital raising.

07/10/2019

Subscription Deeds executed for a two stage share placement to strategic investment companies. First Subscription to raise $2.4m at 0.5 cents per share. Second Subscription to raise $6.9m at 1 cent per share. Funds used to expand Meluka Health and Jenbrook business activities.

07/10/2019

The securities of EVE Investments Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EVE, pending the release of an announcement regarding a capital raising.

30/09/2019

The securities of Eve Investments Limited will be reinstated to official quotation immediately following the release of an announcement.

06/10/2017

Firm commitments have been received for a $1.2m capital raising, including $110k of director participation. A $500k investment was made by an existing shareholder and Chinese pharmaceutical and traditional medicine group "“ TRT Investments Pty Ltd. Funds will be used to complete the Meluka Health investment.

06/10/2017

The Company is continuing discussions with key parties and expects to  resolve the capital raising within the week.

02/10/2017

The securities of Eve Investments Limited will be suspended from official quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising

27/09/2017

The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising and an acquisition.

02/05/2017

The company has entered into an agreement to acquire a 50% interest in an established organic essential oils producer from Jenbrook Pty Ltd whose long"term owner is Bryan Easson, for total consideration of $1.49m. 

01/05/2017

The company lodges its Appendix 4C - Quarterly Report.

28/04/2017

The company is still progressing discussions with potential investors in relation to the capital raising to fund the second tranche investment into Omni Innovation. The requirement to invest a further $625,000 into Omni Innovation has been deferred from 31 March  2017 to 30 April 2017 to allow time for EVE to complete the capital raising process. EVE is in the final stages of negotiating a new investment opportunity. 

21/04/2017

The Company is still progressing discussions with potential investors in relation to the capital raising and will provide shareholders with a further update by Monday, 24 April 2017.

18/04/2017

EVE Investments gives notice that the unaudited Net Tangible Assets (NTA) per share as at 31 March 2017 was $0.0017 per share.

13/04/2017

The company provides an update on the progress of the capital raising that is being conducted to complete the second tranche investment into Omni Innovation. The Company is still progressing discussions with potential investors in relation to the capital raising and will provide shareholders with an update by Tuesday, 18 April 2017.

10/04/2017

The company would like to update shareholders on the progress of the capital raising that is being conducted to complete the second tranche investment into Omni Innovation. The Company is continuing discussions with potential investors and expects to resolve the capital raising within the  week.  A  further  announcement  will  be  provided  to  shareholders  in  due  course,  at  which  point  the  voluntary  suspension will be lifted. 

03/04/2017

The securities of EVE Investments Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising.

27/03/2017

The suspension of trading in the securities of EVE Investments Limited will be lifted before the commencement of trading on Wednesday, 28 December 2016, following the release by the Company of an announcement regarding a capital raising.

23/12/2016

EVE Investments, an ASX-listed technology investment company, is pleased to announce a two-tranche placement to raise up to $1.6m at $0.008.

23/12/2016

EVE Investments gives notice that the unaudited Net Tangible Assets (NTA) per share as at 30 November 2016 was $0.0018 per share.

22/12/2016

EVE Investments advises that the non-renounceable entitlement issue which closed on 6 December 2016 raised less than the minimum funds required under the Offer Document. Accordingly, the entitlement issue has been withdrawn and funds will be returned to applicants on 16 December 2016. EVE is continuing to pursue other capital raising initiatives and expects to update the market on these activities by Monday 19 December 2016, at which time the voluntary suspension will be lifted.

14/12/2016

The securities of EVE Investments Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising.

14/12/2016

The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising.

10/11/2016

EVE will conduct a placement at 1 cent per share to raise $600,000 before costs by issuing 60,000,000 new shares to a new strategic investor, the Tianjin Tongrentang Group via its Australian subsidiary TRT Investment Group. n addition to the placement, EVE will also be offering existing shareholders the opportunity to participate in a non-renounceable entitlement issue at the same price as the placement on a 1:6 basis raising up to $1,959,167. The entitlement issue will be managed by Westar Capital Ltd.

10/11/2016

The securities of Eve Investments Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement in relation to a capital raising.

03/11/2016

name changed from Energy Ventures Limited

04/12/2015

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

This company is so far under the radar, has the Omnibelnd product, under the Fauldings label, first class distribution company and product ready to hit the shelvess with advertizing blitz ciming very soon

10/05/2016 14:15:19

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    21/05/2020Gregory Fry4,000,000$0.006$22,000
    08/11/2018Gregory Fry2,000,000$0.007$14,165
    12/01/2017Gregory Fry1,500,000$0.007$10,500
    18/05/2012Alasdair Cooke2,000,000$0.023$46,506
    09/01/2012Alasdair Cooke286,633$0.031$8,936

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    George Cameron-DowNon Exec Chairman31/03/2016
    Gregory FryManaging Director, CEO18/08/2009
    Ben RohrCOO10/12/2019
    Alasdair CookeNon Exec Director08/01/2007
    Joalin ChouDirector21/01/2020
    Carlos JinDirector10/12/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Michael CurnowNon Exec Director27/04/200631/03/2016
    Lachlan ReynoldsManaging Director20/12/201011/09/2012

    Date of first appointment, title may have changed.